New Jersey 2024-2025 Regular Session

New Jersey Assembly Bill AR110

Introduced
2/22/24  

Caption

Urges President and Congress to enact "Humane Cosmetics Act of 2023."

Impact

If passed, the 'Humane Cosmetics Act of 2023' would prohibit all testing of cosmetics on animals and ban the sale or transport of any cosmetics that utilized animal testing in their development. This transformation would represent a major shift in U.S. cosmetics policy and could significantly reduce animal testing practices both domestically and globally. The resolution notes that many companies already comply with animal testing bans from other countries and argues that American firms would face no economic risk from such a shift in policy, given the availability of cost-effective non-animal testing methods.

Summary

Assembly Resolution No. 110 (AR110) urges the President and Congress of the United States to enact the 'Humane Cosmetics Act of 2023'. This resolution addresses the significant ethical concerns associated with animal testing in the cosmetics industry, highlighting the number of animals that suffer each year during tests designed to evaluate the safety of consumer products and their ingredients. The resolution emphasizes the existence of effective alternatives to animal testing which are already being utilized by many companies in the industry. This act aligns U.S. practices with those of over 30 countries, including the European Union and India, which have implemented similar bans on animal-tested cosmetics.

Contention

While the resolution enjoys broad bipartisan support—with endorsements from over 370 companies in the cosmetics industry—there may still be contention regarding the logistics of enforcement and compliance with international standards. Critics may express concerns about potential impacts on product safety assessments and market competition, particularly from countries that continue to mandate animal testing. Moreover, the transition might pose challenges for smaller companies that may rely more heavily on traditional testing frameworks due to cost or resource constraints.

Companion Bills

NJ AR150

Carry Over Urges President and Congress to enact "Humane Cosmetics Act of 2021."

Similar Bills

NJ AR154

Urges Congress to provide for joint session at Independence Hall in Philadelphia, Pennsylvania, in honor of semiquincentennial of Declaration of Independence.

TX SJR1

Urging the Congress of the United States to propose and submit to the states for ratification a federal balanced budget amendment to the Constitution of the United States and, in the event that Congress does not submit such an amendment on or before December 31, 2011, applying to Congress to call a convention for the specific and exclusive purpose of proposing an amendment to that constitution to provide, in the absence of a national emergency and on a two-thirds vote of Congress, for a federal balanced budget and requesting that the legislatures of each of the several states that compose the United States apply to Congress to call a convention to propose such an amendment.

US HB209

Inaction Has Consequences Act This bill withholds the salaries of Members of a chamber of Congress that has not passed each of the annual appropriations bills before the beginning of the fiscal year, beginning with FY2026. Salaries are released on the earlier of (1) the date on which the chamber of Congress passes the bills, or (2) the last day of the Congress.

US HB157

Citizen Legislature Anti-Corruption Reform of Congress Act or the CLEAN Congress Act This bill (1) requires bills, orders, resolutions, or votes submitted by Congress to the President to include only one subject that is clearly and descriptively expressed in the measure's title; and (2) makes ineffective any provision of law that excludes its application to a Member of Congress or to an employee in a Member's office.

NJ AJR97

Urges U.S. Congress to pass Equal Rights Amendment.

US HB1973

No Pay for Congress During Default or Shutdown Act

US SCR5

This concurrent resolution states that, unless it is approved by Congress, the proposed joint interpretation of Annex 14-C of the United States-Mexico-Canada Agreement (USMCA) prepared by Ambassador Katherine Tai (1) is of no legal effect with respect to the United States or any U.S. person, and (2) cannot be invoked by any federal agency in any legal proceeding nor may a federal agency assert that it has any legal consequences for claims made by a U.S. person. (Annex 14-C of the USMCA concerns certain investment claims under the North American Free Trade Agreement, the agreement which preceded USMCA.)

NJ AJR146

Urges Congress enact legislation granting statehood to Washington, D.C.